The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options ...

Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making ...

which are sold under the brand names Saxenda and Wegovy. Nearly 1 in 3 patients halted treatment within four weeks, before the recommended dosage reached the drugs' targeted strength. Because ...

Saxenda is approved by the FDA for chronic weight ... you must lose at least 5 per cent of your body weight after 12 weeks on the full dose in order to continue with the medication.

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

In the new SCALE Kids study, which has been published in the New England Journal of Medicine, a daily 3mg dose of Saxenda reduced the body mass index (BMI) of the children by an average of 5.8% ...

depending on the dosage, before discounts or insurance, according to Novo Nordisk, which also sells a version of liraglutide approved for obesity, called Saxenda. “There are many people on this ...